{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT03181087",
      "OrgStudyIdInfo": {
        "OrgStudyId": "MCHHFoshan-1701"
      },
      "Organization": {
        "OrgFullName": "Maternal and Child Health Hospital of Foshan",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Safety of Umbilical Cord Mesenchymal Stem Cell Local Intramuscular Injection for Treatment of Uterine Scars",
      "OfficialTitle": "A Phase I, Single-arm, Open Study of the Safety of Umbilical Cord Mesenchymal Stem Cell Local Intramuscular Injection for Treatment of Uterine Scars"
    },
    "StatusModule": {
      "StatusVerifiedDate": "June 2021",
      "OverallStatus": "Recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "December 11, 2021",
        "StartDateType": "Anticipated"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "October 31, 2022",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "May 30, 2023",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "June 7, 2017",
      "StudyFirstSubmitQCDate": "June 7, 2017",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "June 8, 2017",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "June 7, 2021",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "June 9, 2021",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Principal Investigator",
        "ResponsiblePartyInvestigatorFullName": "Zhengping Liu, MD",
        "ResponsiblePartyInvestigatorTitle": "Director",
        "ResponsiblePartyInvestigatorAffiliation": "Maternal and Child Health Hospital of Foshan"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Maternal and Child Health Hospital of Foshan",
        "LeadSponsorClass": "OTHER"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes",
      "IsFDARegulatedDrug": "No",
      "IsFDARegulatedDevice": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "The purpose of this study is to evaluate the safety of umbilical cord mesenchymal stem cell local intramuscular injection for treatment of uterine scars by a prospective, single-center, open, and single-arm clinical trial."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Uterine Scar"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Mesenchymal Stem Cells",
          "Cesarean Section",
          "Uterine Scar"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "N/A",
        "DesignInterventionModel": "Single Group Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "10",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Umbilical cord MSCs Group",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "1*10^7 Umbilical cord Mesenchymal Stem Cells (MSCs)",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Other: Umbilical cord MSCs"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Other",
            "InterventionName": "Umbilical cord MSCs",
            "InterventionDescription": "Participants will receive direct local intramuscular injection of 1*10^7 MSCs (in 1ml of 0.9% saline) in the uterine incision.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Umbilical cord MSCs Group"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Safety evaluation through vital signs, the results of clinical lab tests and adverse events",
            "PrimaryOutcomeDescription": "Safety evaluation through vital signs, the results of clinical lab tests and adverse events.",
            "PrimaryOutcomeTimeFrame": "6 months post treatment"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Number of participants with uterine niche",
            "SecondaryOutcomeDescription": "The niche is defined as a triangular anechoic area at the presumed site of incision in the uterus by transvaginal utrasonography.",
            "SecondaryOutcomeTimeFrame": "6 months post treatment"
          },
          {
            "SecondaryOutcomeMeasure": "Change of uterine scar thickness",
            "SecondaryOutcomeDescription": "The scar thickness be measured using a transvaginal utrasonography",
            "SecondaryOutcomeTimeFrame": "6 weeks, 3 and 6 months post treatment"
          },
          {
            "SecondaryOutcomeMeasure": "Change of uterine scar area",
            "SecondaryOutcomeDescription": "The scar area will be measured using a transvaginal utrasonography",
            "SecondaryOutcomeTimeFrame": "6 weeks, 3 and 6 months post treatment"
          },
          {
            "SecondaryOutcomeMeasure": "Number of participants with endometritis",
            "SecondaryOutcomeDescription": "Endometritis is defined as the presence of at least two of the following signs with no other recognized cause: fever (temperature of at least 38℃), abdominal pain, uterine tenderness, or purulent drainage from the uterus.",
            "SecondaryOutcomeTimeFrame": "6 months post treatment"
          },
          {
            "SecondaryOutcomeMeasure": "Number of participants with wound infection",
            "SecondaryOutcomeDescription": "Wound infection is defined as the presence of either superficial or deep incisional surgical-site infection characterized by cellulitis or erythema and induration around the incision or purulent discharge from the incision site with or without fever and included necrotizing fasciitis.",
            "SecondaryOutcomeTimeFrame": "6 months post treatment"
          },
          {
            "SecondaryOutcomeMeasure": "Immunoglobulin concentrations in breast milk and serum",
            "SecondaryOutcomeDescription": "Breast milk and serum immunoglobulin (IgG, IgA, IgM) and the complement (C3, C4) are detected by transmission immune turbidity method using automatic biochemical analyzer.",
            "SecondaryOutcomeTimeFrame": "6 weeks, 3 and 6 months post treatment"
          },
          {
            "SecondaryOutcomeMeasure": "Adverse events occurrence",
            "SecondaryOutcomeDescription": "Adverse events will be evaluated since the baseline visit until 6 months after the end of the treatment.",
            "SecondaryOutcomeTimeFrame": "6 months post treatment"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nPrimiparous women receiving cesarean delivery\nAges between 21-35 years\nGestation ages ≥ 37 weeks and < 42 weeks\nWilling to comply with study dosing and completed the entire course of the study\nWilling to give and sign an informed consent form and a photographic release form\n\nExclusion Criteria:\n\nFibroids\nPlacenta previa\nPlacenta abruption\nMultiple gestation\nAntepartum hemorrhage\nPreeclampsia/Eclampsia\nHepatic or renal dysfunction\nAny systemic uncontrolled disease\nInability to provide consent",
      "HealthyVolunteers": "Accepts Healthy Volunteers",
      "Gender": "Female",
      "MinimumAge": "21 Years",
      "MaximumAge": "35 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "Zhengping Liu, MD",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "+ 86 757 82969772",
            "CentralContactEMail": "liuzphlk81@outlook.com"
          },
          {
            "CentralContactName": "Dazhi Fan, MD",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "+ 86 757 82969772",
            "CentralContactEMail": "fdz1988@gmail.com"
          }
        ]
      },
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Zhengping Liu, MD",
            "OverallOfficialAffiliation": "Maternal and Child Health Hospital of Foshan",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Maternal and Child Health Hospital of Foshan",
            "LocationStatus": "Recruiting",
            "LocationCity": "Foshan",
            "LocationState": "Guangdong",
            "LocationZip": "528000",
            "LocationCountry": "China",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Deqin Jia, BD",
                  "LocationContactRole": "Contact",
                  "LocationContactPhone": "+ 86 757 82969772",
                  "LocationContactEMail": "trials_fs_mchh@sohu.com"
                },
                {
                  "LocationContactName": "Dazhi Fan, MD",
                  "LocationContactRole": "Sub-Investigator"
                }
              ]
            }
          }
        ]
      }
    },
    "IPDSharingStatementModule": {
      "IPDSharing": "Undecided"
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000002921",
            "ConditionMeshTerm": "Cicatrix"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000005355",
            "ConditionAncestorTerm": "Fibrosis"
          },
          {
            "ConditionAncestorId": "D000010335",
            "ConditionAncestorTerm": "Pathologic Processes"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M5312",
            "ConditionBrowseLeafName": "Cicatrix",
            "ConditionBrowseLeafAsFound": "Scar",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M7637",
            "ConditionBrowseLeafName": "Fibrosis",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          }
        ]
      }
    }
  }
}